Detalles de la búsqueda
1.
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
Br J Clin Pharmacol
; 89(3): 1089-1098, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178950
2.
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.
Int J Mol Sci
; 24(4)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36834713
3.
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
Oncologist
; 27(2): e158-e167, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641220
4.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253871
5.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024268
6.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
7.
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
Oncologist
; 25(8): 661-668, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32202020
8.
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer.
Future Oncol
; 16(32): 2645-2660, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776795
9.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
10.
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Br J Cancer
; 118(6): 878-886, 2018 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449673
11.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
Br J Cancer
; 119(5): 565-571, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30057406
12.
Author Correction: The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Br J Cancer
; 118(12): 1684, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29780160
13.
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
N Engl J Med
; 371(17): 1609-18, 2014 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25337750
14.
UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population.
Liver Int
; 37(9): 1345-1353, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28294511
15.
A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma.
Anticancer Drugs
; 28(10): 1157-1165, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926423
16.
HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
Int J Mol Sci
; 18(7)2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653974
17.
Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.
Int J Mol Sci
; 19(1)2017 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29295527
18.
Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
Ann Surg Oncol
; 23(13): 4302-4309, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27489059
19.
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
Int J Mol Sci
; 17(9)2016 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27608007
20.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Int J Cancer
; 137(12): 2971-80, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099996